Institutional Ownership Werewolf Therapeutics, Inc. (HOWL)
This table provides information about the institutional ownership of Werewolf Therapeutics, Inc. (HOWL). We have compiled data on the 73 institutions that hold shares in the stock, with a total of 28 Million shares, which have been reported (via 13F filing form) to have a value of $40.5 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,144,881
shares
|
$8.48 Million
0.15% of portfolio
|
Q2 2024
New holding
|
|
Mpm Asset Management LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
4,284,172
shares
|
$5.91 Million
5.1% of portfolio
|
Q2 2021
New holding
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,905,465
shares
|
$4.01 Million
0.28% of portfolio
|
Q4 2024
Reduced 14.51%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
2,388,011
shares
|
$3.3 Million
0.53% of portfolio
|
Q2 2021
New holding
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
2,078,875
shares
|
$2.87 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.48%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,587,724
shares
|
$2.19 Million
0.0% of portfolio
|
Q2 2024
Added 863.47%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,420,969
shares
|
$1.96 Million
0.0% of portfolio
|
Q4 2024
Added 0.38%
|
|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,333,893
shares
|
$1.84 Million
0.03% of portfolio
|
Q2 2024
Reduced 17.71%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
702,558
shares
|
$969,530
0.0% of portfolio
|
Q4 2024
Added 2.42%
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
626,810
shares
|
$864,997
0.19% of portfolio
|
Q3 2022
Added 4.99%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
596,289
shares
|
$822,878
0.0% of portfolio
|
Q4 2024
Reduced 54.96%
|
|
Dc Funds, LP
Mclean, VA |
Feb 14, 2025 Q4 2024 |
589,102
shares
|
$812,960
17.55% of portfolio
|
Q1 2022
Added 1.41%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
426,772
shares
|
$588,945
0.0% of portfolio
|
Q4 2024
Reduced 10.42%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
244,390
shares
|
$337,258
0.0% of portfolio
|
Q4 2024
Added 7.31%
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
242,264
shares
|
$334,324
0.0% of portfolio
|
Q4 2024
Reduced 8.7%
|
|
Bit Capital Gmb H
Berlin, 2M |
Feb 12, 2025 Q4 2024 |
241,056
shares
|
$332,657
0.03% of portfolio
|
Q3 2024
Added 3.29%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
235,705
shares
|
$325,272
0.0% of portfolio
|
Q1 2024
Reduced 45.9%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
194,746
shares
|
$268,749
0.0% of portfolio
|
Q4 2024
Reduced 24.47%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
141,830
shares
|
$195,725
0.0% of portfolio
|
Q4 2024
Added 23.18%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
139,100
shares
|
$191,957
0.0% of portfolio
|
Q4 2024
Reduced 45.73%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
138,142
shares
|
$190,635
0.0% of portfolio
|
Q4 2024
Added 16.05%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
109,586
shares
|
$151,228
0.0% of portfolio
|
Q4 2024
Added 24.41%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
101,626
shares
|
$140,243
0.0% of portfolio
|
Q4 2024
Added 450.7%
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
96,850
shares
|
$133,653
0.0% of portfolio
|
Q4 2024
Reduced 11.12%
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
93,440
shares
|
$128,947
0.0% of portfolio
|
Q4 2024
Reduced 48.26%
|